119 related articles for article (PubMed ID: 6172476)
1. Chido and Rogers antigenic determinant on the fourth component of human complement.
Chu VF; Marsh WL; Gigli I
J Immunol; 1982 Jan; 128(1):181-5. PubMed ID: 6172476
[TBL] [Abstract][Full Text] [Related]
2. Rodgers (Rg) and Chido (Ch) determinants on human C4: characterization of two C4 B5 subtypes, one of which contains Rg and Ch determinants.
Roos MH; Giles CM; Demant P; Mollenhauer E; Rittner C
J Immunol; 1984 Nov; 133(5):2634-40. PubMed ID: 6207239
[TBL] [Abstract][Full Text] [Related]
3. Antigenic determinants of human C4, Rodgers and Chido.
Giles CM
Exp Clin Immunogenet; 1988; 5(2-3):99-114. PubMed ID: 2483343
[TBL] [Abstract][Full Text] [Related]
4. Chido, Rodgers and C4. In vivo and in vitro coating of red blood cells, grouping and antibody detection.
Nordhagen R; Heier Larsen AM; Beckers D
Vox Sang; 1979; 37(3):170-8. PubMed ID: 91269
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4.
Taillon-Miller PA; Shreffler DC
J Immunol; 1988 Oct; 141(7):2382-7. PubMed ID: 2459207
[TBL] [Abstract][Full Text] [Related]
6. The rapid identification of Chido and Rodgers antibodies using C4d-coated red blood cells.
Judd WJ; Kraemer K; Moulds JJ
Transfusion; 1981; 21(2):189-92. PubMed ID: 7222201
[TBL] [Abstract][Full Text] [Related]
7. The significance of red cell bound complement components in development of standards and quality assurance for the anti-complement components of antiglobulin sera.
Garratty G; Petz LD
Transfusion; 1976; 16(4):297-306. PubMed ID: 951725
[TBL] [Abstract][Full Text] [Related]
8. The fourth component of human complement treated with amines or chaotropes or frozen-thawed (C4b-like C4): interaction with C4 binding protein and cleavage by C3b/C4b inactivator.
von Zabern I; Bloom EL; Chu V; Gigli I
J Immunol; 1982 Mar; 128(3):1433-8. PubMed ID: 6976993
[TBL] [Abstract][Full Text] [Related]
9. Mouse C4 (Ss): three-step purification of its C4c fragment and production of a monospecific antiserum.
Ferreira A; Nussenzweig V
J Immunol; 1979 Feb; 122(2):490-3. PubMed ID: 762433
[TBL] [Abstract][Full Text] [Related]
10. In vivo and in vitro binding of C4 molecules on red cells: a correlation of numbers of molecules and agglutination.
Giles CM; Davies KA; Walport MJ
Transfusion; 1991; 31(3):222-8. PubMed ID: 1706118
[TBL] [Abstract][Full Text] [Related]
11. Preparation of antibodies against the fourth complement component (C4) and development of a direct electroimmunoassay for quantification of C4d.
Folkersen J; Teisner B; Petersen NE; Sim RB; Jessen E
J Clin Lab Immunol; 1985 Mar; 16(3):163-7. PubMed ID: 4032454
[TBL] [Abstract][Full Text] [Related]
12. Activation of the fourth component of complement (C4): assessment by rocket immunoelectrophoresis and correlation with the metabolism of C4.
Milgrom H; Curd JG; Kaplan RA; Müller-Eberhard HJ; Vaughan JH
J Immunol; 1980 Jun; 124(6):2780-5. PubMed ID: 7373050
[TBL] [Abstract][Full Text] [Related]
13. Expression of MHC class I determinants on erythrocytes of SLE patients.
Giles CM; Walport MJ; David J; Darke C
Clin Exp Immunol; 1987 Aug; 69(2):368-74. PubMed ID: 3308228
[TBL] [Abstract][Full Text] [Related]
14. Conversion of the C4d.2 serologic allotype of murine complement component C4 to the C4d.1 allotype by site-specific mutagenesis.
Mathias P; Shreffler DC; Cooper NR; Ogata RT
J Immunol; 1990 Jan; 144(2):607-9. PubMed ID: 2295802
[TBL] [Abstract][Full Text] [Related]
15. Antigenic determinants expressed by human C4 allotypes; a study of 325 families provides evidence for the structural antigenic model.
Giles CM; Uring-Lambert B; Goetz J; Hauptmann G; Fielder AH; Ollier W; Rittner C; Robson T
Immunogenetics; 1988; 27(6):442-8. PubMed ID: 2453461
[TBL] [Abstract][Full Text] [Related]
16. The murine H-2.7 specificity is an antigenic determinant of C4d, a fragment of the fourth component of the complement system.
Ferreira A; David CS; Nussenzweig V
J Exp Med; 1980 Jun; 151(6):1424-35. PubMed ID: 6155423
[TBL] [Abstract][Full Text] [Related]
17. The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4.
Isenman DE; Young JR
J Immunol; 1984 Jun; 132(6):3019-27. PubMed ID: 6609966
[TBL] [Abstract][Full Text] [Related]
18. [C4d]FlowPRA screening--a specific assay for selective detection of complement-activating anti-HLA alloantibodies.
Wahrmann M; Exner M; Haidbauer B; Schillinger M; Regele H; Körmöczi G; Böhmig GA
Hum Immunol; 2005 May; 66(5):526-34. PubMed ID: 15935890
[TBL] [Abstract][Full Text] [Related]
19. Studies on the antibody composition and neutralizing activity of tetanus antitoxin sera from various species of animals in relation to the antigenic substructure of the tetanus toxin molecule.
Matsuda M; Makinaga G; Hirai T
Biken J; 1983 Dec; 26(4):133-43. PubMed ID: 6204634
[TBL] [Abstract][Full Text] [Related]
20. Localisation of Chido and Rodgers determinants to the C4d fragment of human C4.
Tilley CA; Romans DG; Crookston MC
Nature; 1978 Dec; 276(5689):713-5. PubMed ID: 83538
[No Abstract] [Full Text] [Related]
[Next] [New Search]
